Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCD | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCD	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, kidney disorder, minimal change disease, nephrosis, urinary system disorder	Not yet recruiting	Phase 3	2024-05-08		NCT06405100

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Air Force Military Medical University, China	39
First Affiliated Hospital Xi'an Jiaotong University	142
Second Affiliated Hospital of Xi'an Jiaotong University	33
Shaanxi Provincial Hospital of Chinese Medicine	2
Shaanxi Provincial People's Hospital	20
The Second Affiliated Hospital of Air Force Military Medical University	8

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.